From mobile jobs to nature photography, BLUETTI aims at all profiles. The fast charging of Canon, DJI, or Apple batteries ensures the success of photo shoots away from the grid. The station thus ...

Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...

Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

Newer therapies improve inflammatory rosacea, yet additional research is needed to help clinicians manage vascular, ...

Bristol-Myers Squibb's key drugs are losing patent protection, while more recently launched drugs are struggling to meet peak ...

US drug makers are racing to plug looming 'patent cliff' revenue gaps - and increasingly they are turning to China biotechs ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

The deal adds some of the biggest names in drug manufacturing to the president's "most favored nation" pricing plan.

BMS signed a multiyear agreement with antibody specialist Harbour BioMed, which has operations in the US, the Netherlands, ...

The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

Approximately 20% of ischemic strokes involve the posterior circulation, primarily supplied by the vertebrobasilar system. While much is known about the stroke risk of vertebrobasilar stenotic disease ...

Iberdomide and mezigdomide are currently being evaluated for the treatment of patients with multiple myeloma in a number of ...